Part 9/13:
The systemic corruption extends into law enforcement and regulatory agencies. Former FBI officials, who now migrate into lucrative roles within the insurance and pharmaceutical sectors, exemplify conflicts of interest. The "capture" of agencies like the FDA and DOJ by corporate interests allows deceptive practices to flourish, enabling big companies to manipulate policies, evade accountability, and silence critics.
Legal strategies—including filing fraudulent claims, intimidating healthcare providers, and asset seizure—are used to crush whistleblowers and small practitioners. The narrative points out that the justice system, often influenced by corporate collusion, acts as an arm of these industries rather than an enforcer of accountability.